
    
      Randomised placebo-controlled trial (therapeutic vs. subtherapeutic continuous positive
      airway pressure [CPAP]) including 30 OSA patients to define the effects of CPAP withdrawal
      (subtherapeutic CPAP) on the composition of exhaled breath analysed by mass spectrometry for
      identification of OSA specific markers.
    
  